Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Radiolabelled peptides: now and the future

M L Thakur1

  • 1Department of Radiology, Thomas Jefferson University Hospital, Philadelphia, PA 19107, USA.

Nuclear Medicine Communications
|September 1, 1995
PubMed
Summary

Radiolabeled peptides are valuable radiopharmaceuticals for diagnosing endocrine tumors. Technetium-99m (99Tcm) offers advantages for labeling peptides, enabling improved diagnostic imaging and therapeutic applications.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Radiohybridization PET imaging of KRAS G12D mRNA expression in human pancreas cancer xenografts with [(64)Cu]DO3A-peptide nucleic acid-peptide nanoparticles.

Cancer biology & therapy·2007
Same author

Receptor-mediated internalization of chelator-PNA-peptide hybridization probes for radioimaging or magnetic resonance imaging of oncogene mRNAs in tumours.

Biochemical Society transactions·2007
Same author

Stem cells: a regenerative pharmaceutical.

The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of...·2006
Same author

99mTc-Fanolesomab: affinity, pharmacokinetics and preliminary evaluation.

The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of...·2006
Same author

Synthesis of novel peptide nucleic acid-peptide chimera for non-invasive imaging of cancer.

Nucleosides, nucleotides & nucleic acids·2005
Same author

Tumor-targeting peptide-PNA-peptide chimeras for imaging overexpressed oncogene mRNAs.

Nucleosides, nucleotides & nucleic acids·2005

Area of Science:

  • Nuclear medicine
  • Radiopharmaceutical chemistry
  • Endocrinology

Background:

  • Peptides are naturally occurring molecules with diverse biological functions.
  • Radiolabeled peptides are emerging as crucial tools in nuclear medicine for diagnostic imaging.
  • Technetium-99m (99Tcm) is the preferred radionuclide for peptide labeling due to its favorable characteristics.

Purpose of the Study:

  • To review the development and evaluation of radiolabeled peptides for diagnostic applications.
  • To highlight the advantages of using 99Tcm for peptide radiolabeling.
  • To discuss challenges and considerations in the preparation and preclinical evaluation of these agents.

Main Methods:

  • Review of existing literature on radiolabeled peptides.
  • Discussion of labeling techniques, including direct labeling and bifunctional chelators.
  • Emphasis on receptor binding assays and preclinical models for evaluation.
  • Importance of control studies with non-specific peptides.

Main Results:

  • Clinical results with 111In- and 125I-labeled peptides have been successful.
  • 99Tcm-labeled peptides offer cost-effectiveness, availability, and suitable nuclear properties.
  • Both direct labeling and bifunctional chelator methods are employed, with varying efficiencies.
  • Preclinical evaluations require rigorous testing, including specificity and safety assessments.

Conclusions:

  • Radiolabeled peptides, particularly those labeled with 99Tcm, represent a promising class of radiopharmaceuticals.
  • Continued research and development in this area are essential for advancing diagnostic and therapeutic applications.
  • Careful evaluation, including control studies and safety assessments, is critical for clinical success.

Related Experiment Videos